Dactolisib outperforms Rapamycin in potentiating apoptosis induced by <scp>XPO1</scp> , Bcl‐2 and Mcl‐1 blockade in preclinical glioblastoma models

Kai Zhao, Leonie Meyer, Madita Braun, Katharina Otte, Celine Bitter, Maite Pawlik, Hartmann Raifer, Frederik Helmprobst, Axel Pagenstecher, Hans Urban, Michael C. Burger, Michael W. Ronellenfitsch, Joachim P. Steinbach, Jarmila Jedelská, Shamim Bagheri, Behrooz H. Yousefi, Pietro Di Fazio, Markus Luster, Andreas H. Mahnken, Andreas Neubauer, Andreas Burchert, Christopher Nimsky, Jörg W. Bartsch, Tillmann Rusch

Open source

DOI
10.1002/2211-5463.70357
Published
2026-10-24
Container
FEBS Open Bio
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/2211-5463.70357,
  title = {Dactolisib outperforms Rapamycin in potentiating apoptosis induced by
                    <scp>XPO1</scp>
                    , Bcl‐2 and Mcl‐1 blockade in preclinical glioblastoma models},
  author = {Kai Zhao and Leonie Meyer and Madita Braun and Katharina Otte and Celine Bitter and Maite Pawlik and Hartmann Raifer and Frederik Helmprobst and Axel Pagenstecher and Hans Urban and Michael C. Burger and Michael W. Ronellenfitsch and Joachim P. Steinbach and Jarmila Jedelská and Shamim Bagheri and Behrooz H. Yousefi and Pietro Di Fazio and Markus Luster and Andreas H. Mahnken and Andreas Neubauer and Andreas Burchert and Christopher Nimsky and Jörg W. Bartsch and Tillmann Rusch},
  year = {2026},
  journal = {FEBS Open Bio},
  doi = {10.1002/2211-5463.70357},
  url = {https://doi.org/10.1002/2211-5463.70357}
}

RIS

TY  - JOUR
TI  - Dactolisib outperforms Rapamycin in potentiating apoptosis induced by
                    <scp>XPO1</scp>
                    , Bcl‐2 and Mcl‐1 blockade in preclinical glioblastoma models
AU  - Kai Zhao
AU  - Leonie Meyer
AU  - Madita Braun
AU  - Katharina Otte
AU  - Celine Bitter
AU  - Maite Pawlik
AU  - Hartmann Raifer
AU  - Frederik Helmprobst
AU  - Axel Pagenstecher
AU  - Hans Urban
AU  - Michael C. Burger
AU  - Michael W. Ronellenfitsch
AU  - Joachim P. Steinbach
AU  - Jarmila Jedelská
AU  - Shamim Bagheri
AU  - Behrooz H. Yousefi
AU  - Pietro Di Fazio
AU  - Markus Luster
AU  - Andreas H. Mahnken
AU  - Andreas Neubauer
AU  - Andreas Burchert
AU  - Christopher Nimsky
AU  - Jörg W. Bartsch
AU  - Tillmann Rusch
PY  - 2026
JO  - FEBS Open Bio
DO  - 10.1002/2211-5463.70357
UR  - https://doi.org/10.1002/2211-5463.70357
ER  - 

APA

Zhao, K., Meyer, L., Braun, M., Otte, K., Bitter, C., Pawlik, M., Raifer, H., Helmprobst, F., Pagenstecher, A., Urban, H., Burger, M. C., Ronellenfitsch, M. W., Steinbach, J. P., Jedelská, J., Bagheri, S., Yousefi, B. H., Fazio, P. D., Luster, M., Mahnken, A. H., Neubauer, A., Burchert, A., Nimsky, C., Bartsch, J. W., & Rusch, T. (2026). Dactolisib outperforms Rapamycin in potentiating apoptosis induced by <scp>XPO1</scp> , Bcl‐2 and Mcl‐1 blockade in preclinical glioblastoma models. FEBS Open Bio. https://doi.org/10.1002/2211-5463.70357

Source records